This approval is important because it demonstrates what legitimate needle-free GLP-1 therapy requires
Aim for protein at every meal
This effect is thought to be mediated by increasing natriuresis (35) and vasorelaxation in the renal vasculature (36)
In contrast, GLP-1 receptor agonists approved by the FDAincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound, which also activates GIP receptors)are modified to resist DPP-4 degradation
Before committing, review how a provider sources and prepares its medications
Available options range from temporary cessation of breastfeeding (combined with brief formula use and milk expression/storage) to continued nursing with close infant monitoring